Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation

Abstract Background Macroscopic diffuse-type hepatocellular carcinoma with concomitant major portal vein tumor thrombus (PVTT) and peritoneal dissemination indicates poor prognosis. Additionally, triple-positive tumor marker status is a predictor of poor outcome even after hepatectomy. Sorafenib is...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuki Koga, Toru Beppu, Katsunori Imai, Kunitaka Kuramoto, Tatsunori Miyata, Yuki Kitano, Shigeki Nakagawa, Hirohisa Okabe, Kazutoshi Okabe, Yo-ichi Yamashita, Akira Chikamoto, Hideo Baba
Format: Article
Language:English
Published: Japan Surgical Society 2018-08-01
Series:Surgical Case Reports
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40792-018-0510-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850051163094777856
author Yuki Koga
Toru Beppu
Katsunori Imai
Kunitaka Kuramoto
Tatsunori Miyata
Yuki Kitano
Shigeki Nakagawa
Hirohisa Okabe
Kazutoshi Okabe
Yo-ichi Yamashita
Akira Chikamoto
Hideo Baba
author_facet Yuki Koga
Toru Beppu
Katsunori Imai
Kunitaka Kuramoto
Tatsunori Miyata
Yuki Kitano
Shigeki Nakagawa
Hirohisa Okabe
Kazutoshi Okabe
Yo-ichi Yamashita
Akira Chikamoto
Hideo Baba
author_sort Yuki Koga
collection DOAJ
description Abstract Background Macroscopic diffuse-type hepatocellular carcinoma with concomitant major portal vein tumor thrombus (PVTT) and peritoneal dissemination indicates poor prognosis. Additionally, triple-positive tumor marker status is a predictor of poor outcome even after hepatectomy. Sorafenib is recommended in such patients, but it has limited therapeutic effectiveness. Case presentation A 54-year-old man was diagnosed with a liver abscess that was treated by puncture and drainage at a regional hospital. However, the diagnosis was subsequently changed to hepatocellular carcinoma with macroscopic portal vein tumor thrombus, based on the results obtained for the triple-positive tumor markers (alpha-fetoprotein, 45,928 ng/ml; protein induced by vitamin K absence or antagonist-II, 125,350 mAU/ml; and alpha-fetoprotein-L3, 38.3%). As the patient’s liver functional reserve was not adequate for curative resection, chemoembolization was performed with a hepatic arterial infusion of cisplatin (50 mg) and 5-FU (1000 mg), followed by mild embolization with cisplatin (50 mg) suspended in lipiodol (5 ml) and starch microspheres (300 mg) containing mitomycin C (4 mg). As the thrombus had progressed to the bifurcation of the right and left portal veins, the right vein was surgically ligated. Three peritoneal nodules could be identified and were removed. Three additional rounds of hepatic arterial chemotherapy/chemoembolization were performed after the initial surgery. At the 2-year evaluation, all tumor markers were observed to have normalized and diagnostic imaging showed complete remission. Conclusions Complete remission of hepatocellular carcinoma with macroscopic portal vein tumor thrombus and peritoneal dissemination was obtained with a treatment regimen that involved four rounds of hepatic arterial infusion chemotherapy and transient chemoembolization, portal vein ligation, and the removal of peritoneal dissemination. This regimen can be recommended for patients with advanced hemiliver lesions who cannot undergo curative resection.
format Article
id doaj-art-55dd56abe35d46649bb5ee7da8f4b91c
institution DOAJ
issn 2198-7793
language English
publishDate 2018-08-01
publisher Japan Surgical Society
record_format Article
series Surgical Case Reports
spelling doaj-art-55dd56abe35d46649bb5ee7da8f4b91c2025-08-20T02:53:15ZengJapan Surgical SocietySurgical Case Reports2198-77932018-08-01411610.1186/s40792-018-0510-8Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligationYuki Koga0Toru Beppu1Katsunori Imai2Kunitaka Kuramoto3Tatsunori Miyata4Yuki Kitano5Shigeki Nakagawa6Hirohisa Okabe7Kazutoshi Okabe8Yo-ichi Yamashita9Akira Chikamoto10Hideo Baba11Department of Surgery, Yamaga City Medical CenterDepartment of Surgery, Yamaga City Medical CenterDepartment of Gastroenterological Surgery, Graduate School of Life Sciences Kumamoto UniversityDepartment of Surgery, Yamaga City Medical CenterDepartment of Gastroenterological Surgery, Graduate School of Life Sciences Kumamoto UniversityDepartment of Gastroenterological Surgery, Graduate School of Life Sciences Kumamoto UniversityDepartment of Gastroenterological Surgery, Graduate School of Life Sciences Kumamoto UniversityDepartment of Gastroenterological Surgery, Graduate School of Life Sciences Kumamoto UniversityDepartment of Gastroenterological Surgery, Graduate School of Life Sciences Kumamoto UniversityDepartment of Gastroenterological Surgery, Graduate School of Life Sciences Kumamoto UniversityDepartment of Gastroenterological Surgery, Graduate School of Life Sciences Kumamoto UniversityDepartment of Gastroenterological Surgery, Graduate School of Life Sciences Kumamoto UniversityAbstract Background Macroscopic diffuse-type hepatocellular carcinoma with concomitant major portal vein tumor thrombus (PVTT) and peritoneal dissemination indicates poor prognosis. Additionally, triple-positive tumor marker status is a predictor of poor outcome even after hepatectomy. Sorafenib is recommended in such patients, but it has limited therapeutic effectiveness. Case presentation A 54-year-old man was diagnosed with a liver abscess that was treated by puncture and drainage at a regional hospital. However, the diagnosis was subsequently changed to hepatocellular carcinoma with macroscopic portal vein tumor thrombus, based on the results obtained for the triple-positive tumor markers (alpha-fetoprotein, 45,928 ng/ml; protein induced by vitamin K absence or antagonist-II, 125,350 mAU/ml; and alpha-fetoprotein-L3, 38.3%). As the patient’s liver functional reserve was not adequate for curative resection, chemoembolization was performed with a hepatic arterial infusion of cisplatin (50 mg) and 5-FU (1000 mg), followed by mild embolization with cisplatin (50 mg) suspended in lipiodol (5 ml) and starch microspheres (300 mg) containing mitomycin C (4 mg). As the thrombus had progressed to the bifurcation of the right and left portal veins, the right vein was surgically ligated. Three peritoneal nodules could be identified and were removed. Three additional rounds of hepatic arterial chemotherapy/chemoembolization were performed after the initial surgery. At the 2-year evaluation, all tumor markers were observed to have normalized and diagnostic imaging showed complete remission. Conclusions Complete remission of hepatocellular carcinoma with macroscopic portal vein tumor thrombus and peritoneal dissemination was obtained with a treatment regimen that involved four rounds of hepatic arterial infusion chemotherapy and transient chemoembolization, portal vein ligation, and the removal of peritoneal dissemination. This regimen can be recommended for patients with advanced hemiliver lesions who cannot undergo curative resection.http://link.springer.com/article/10.1186/s40792-018-0510-8Hepatocellular carcinomaPortal vein tumor thrombusPeritoneal disseminationComplete remissionChemoembolizationPortal vein ligation
spellingShingle Yuki Koga
Toru Beppu
Katsunori Imai
Kunitaka Kuramoto
Tatsunori Miyata
Yuki Kitano
Shigeki Nakagawa
Hirohisa Okabe
Kazutoshi Okabe
Yo-ichi Yamashita
Akira Chikamoto
Hideo Baba
Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation
Surgical Case Reports
Hepatocellular carcinoma
Portal vein tumor thrombus
Peritoneal dissemination
Complete remission
Chemoembolization
Portal vein ligation
title Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation
title_full Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation
title_fullStr Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation
title_full_unstemmed Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation
title_short Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation
title_sort complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation
topic Hepatocellular carcinoma
Portal vein tumor thrombus
Peritoneal dissemination
Complete remission
Chemoembolization
Portal vein ligation
url http://link.springer.com/article/10.1186/s40792-018-0510-8
work_keys_str_mv AT yukikoga completeremissionofadvancedhepatocellularcarcinomafollowingtransientchemoembolizationandportalveinligation
AT torubeppu completeremissionofadvancedhepatocellularcarcinomafollowingtransientchemoembolizationandportalveinligation
AT katsunoriimai completeremissionofadvancedhepatocellularcarcinomafollowingtransientchemoembolizationandportalveinligation
AT kunitakakuramoto completeremissionofadvancedhepatocellularcarcinomafollowingtransientchemoembolizationandportalveinligation
AT tatsunorimiyata completeremissionofadvancedhepatocellularcarcinomafollowingtransientchemoembolizationandportalveinligation
AT yukikitano completeremissionofadvancedhepatocellularcarcinomafollowingtransientchemoembolizationandportalveinligation
AT shigekinakagawa completeremissionofadvancedhepatocellularcarcinomafollowingtransientchemoembolizationandportalveinligation
AT hirohisaokabe completeremissionofadvancedhepatocellularcarcinomafollowingtransientchemoembolizationandportalveinligation
AT kazutoshiokabe completeremissionofadvancedhepatocellularcarcinomafollowingtransientchemoembolizationandportalveinligation
AT yoichiyamashita completeremissionofadvancedhepatocellularcarcinomafollowingtransientchemoembolizationandportalveinligation
AT akirachikamoto completeremissionofadvancedhepatocellularcarcinomafollowingtransientchemoembolizationandportalveinligation
AT hideobaba completeremissionofadvancedhepatocellularcarcinomafollowingtransientchemoembolizationandportalveinligation